Biotech Fund L.p. Efficacy, 10% Owner at REPROS THERAPEUTICS INC. (RPRX), sold 541,000 shares at $0.70 ($381K) on 2009-12-02, disclosed to the SEC on 2009-12-02.
Open-market sale of $381k RPRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 148,000 | $105K | 27.5% |
| 2 | $0.71 | 131,000 | $93K | 24.4% |
| 3 | $0.70 | 262,000 | $183K | 48.1% |
| Total | $0.71 avg | 541,000 | $381K | 100% |